Synovus Financial’s Manhattan Associates MANH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$571K Sell
2,788
-7
-0.3% -$1.48K 0.01% 658
2025
Q2
$552K Buy
2,795
+89
+3% +$16.2K 0.01% 639
2025
Q1
$468K Buy
+2,706
New +$564K 0.01% 670
2020
Q3
Sell
-124
Closed -$12K 1135
2020
Q2
$12K Sell
124
-137
-52% -$10.2K ﹤0.01% 1183
2020
Q1
$13K Buy
261
+137
+110% +$9.87K ﹤0.01% 1502
2019
Q4
$10K Hold
124
﹤0.01% 1208
2019
Q3
$10K Hold
124
﹤0.01% 1186
2019
Q2
$9K Hold
124
﹤0.01% 1135
2019
Q1
$7K Hold
124
﹤0.01% 1175
2018
Q4
$5K Sell
124
-11
-8% -$521 ﹤0.01% 1196
2018
Q3
$8K Buy
+135
New +$7.2K ﹤0.01% 1163
2017
Q3
Sell
-12,687
Closed -$612K 681
2017
Q2
$612K Buy
12,687
+4,677
+58% +$222K 0.01% 377
2017
Q1
$419K Buy
8,010
+1,292
+19% +$65.1K 0.01% 396
2016
Q4
$356K Buy
6,718
+2,850
+74% +$152K 0.01% 396
2016
Q3
$224K Buy
+3,868
New +$233K 0.01% 476

Other funds holding MANH

Synovus Financial's MANH Position: Q3 2025 in Review

Synovus Financial reduced its Manhattan Associates (MANH) stake by 0.25% in Q3 2025, selling an estimated $1.48K and leaving 2,788 shares worth $571K. The position accounts for 0.01% of the portfolio, ranked #658.

Synovus Financial first reported a position in MANH in Q3 2016 and has held it in 15 quarters since. The position peaked at $612K in Q2 2017. 618 funds tracked by Wall St. Rank hold MANH as of Q3 2025.

  • Synovus Financial held 2,788 shares of Manhattan Associates worth $571K as of Q3 2025.
  • Synovus Financial sold 7 Manhattan Associates shares in Q3 2025, an estimated $1.48K.
  • Manhattan Associates made up 0.01% of Synovus Financial's portfolio in Q3 2025, its #658 holding.
  • Synovus Financial first reported a position in Manhattan Associates in Q3 2016 and has held it in 15 quarters since.
  • Synovus Financial's Manhattan Associates position peaked at $612K in Q2 2017.
  • 618 funds tracked by Wall St. Rank held Manhattan Associates as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.